(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile hydrobromide, 97%, 1g

Iloperidone metabolite Hydroxy Iloperidone, 50mg

(S)-4-(TERT-BUTOXYCARBONYL)-4-AZASPIRO[2.4]HEPTANE-5-CARBOXYLIC ACID, 95.0%, 1g

4-Hydroxycarbazole>98.0%(HPLC)1g

Iron (III) chloride, min. 98.5%, ultra pure, anhydrous, 250 g, glass packaging

GC capillary column ROTI®Cap-1, 30 m, 0.32 mm, 3.00 µm, 1 Piece(s)

Perfluorophenyl 6-((tetrahydro-2H-pyran-4-yl)oxy)nicotinate, 98%, 250mg

Indole-3-carboxaldehyde>98.0%(GC)5g

N-(2-Amino-2-oxoethyl)acrylamide, 97%, 10g

Methyl 3-bromo-1H-indazole-6-carboxylate, 95.0%, 100g

Di-tert-butyl fumarate, 95.0%, 5g

L-Serine, min. 98.5%, Ph.Eur., 500 g, plastic packaging.

TEMPO, min. 98%, for synthesis, 5 g, glass packaging